“To amend the Internal Revenue Code of 1986 to provide an income tax credit for the costs of infertility treatments.”
No CRS summary available for this bill.
This section establishes a new tax credit under new IRC §23A equal to 50% of qualified infertility treatment expenses (i.e., costs for infertility treatment or preemptive fertility preservation by U.S.-licensed physicians, including for iatrogenic infertility from medical treatments such as chemotherapy) paid by an eligible individual (i.e., one diagnosed with infertility or facing potential involuntary infertility from medical treatment). The credit is subject to (1) a per-taxpayer lifetime cap equal to the adoption credit's annual limit under IRC §23(b)(1) minus prior years' credits; (2) phaseout for adjusted gross income (AGI) exceeding the adoption credit's phaseout threshold under IRC §23(b)(2)(A)(i) over a $40,000 range (determined without regard to certain foreign earned income exclusions); (3) refundability up to $5,000 ($inflation-adjusted after 2025 using 2024 as base year); and (4) denial for expenses reimbursed by insurance, grants, or other tax benefits. Unused nonrefundable credits carry forward up to five years on a first-in, first-out basis, and married individuals must file jointly to claim the credit.